Navigation Links
Stem cell therapy makes cloudy corneas clear, according to Pitt researchers
Date:4/8/2009

PITTSBURGH, April 9 Stem cells collected from human corneas restore transparency and don't trigger a rejection response when injected into eyes that are scarred and hazy, according to experiments conducted in mice by researchers at the University of Pittsburgh School of Medicine. Their study will be published in the journal Stem Cells and appears online today.

The findings suggest that cell-based therapies might be an effective way to treat human corneal blindness and vision impairment due to the scarring that occurs after infection, trauma and other common eye problems, said senior investigator James L. Funderburgh, Ph.D., associate professor, Department of Ophthalmology. The Pitt corneal stem cells were able to remodel scar-like tissue back to normal.

"Our experiments indicate that after stem cell treatment, mouse eyes that initially had corneal defects looked no different than mouse eyes that had never been damaged," Dr. Funderburgh said.

The ability to grow millions of the cells in the lab could make it possible to create an off-the-shelf product, which would be especially useful in countries that have limited medical and surgical resources but a great burden of eye disease due to infections and trauma.

"Corneal scars are permanent, so the best available solution is corneal transplant," Dr. Funderburgh said. "Transplants have a high success rate, but they don't last forever. The current popularity of LASIK corrective eye surgery is expected to substantially reduce the availability of donor tissue because the procedure alters the cornea in a way that makes it unsuitable for transplantation."

A few years ago, Dr. Funderburgh and other University of Pittsburgh researchers identified stem cells in a layer of the cornea called the stroma, and they recently showed that even after many rounds of expansion in the lab, these cells continued to produce the biochemical components, or matrix, of the cornea. One such protein is called lumican, which plays a critical role in giving the cornea the correct structure to make it transparent.

Mice that lack the ability to produce lumican develop opaque areas of their corneas comparable to the scar tissue that human eyes form in response to trauma and inflammation, Dr. Funderburgh said. But three months after the lumican-deficient mouse eyes were injected with human adult corneal stem cells, transparency was restored.

The cornea and its stromal stem cells themselves appear to be "immune privileged," meaning they don't trigger a significant immune response even when transplanted across species, as in the Pitt experiments.

"Several kinds of experiments indicated that the human cells were alive and making lumican, and that the tissue had rebuilt properly," Dr. Funderburgh noted.

In the next steps, the researchers intend to use the stem cells to treat lab animals that have corneal scars to see if they, too, can be repaired with stem cells. Under the auspices of UPMC Eye Center's recently established Center for Vision Restoration, they plan also to develop the necessary protocols to enable clinical testing of the cells.


'/>"/>

Contact: Anita Srikameswaran
SrikamAV@upmc.edu
412-647-3555
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Related biology news :

1. A new radiation therapy treatment developed for head and neck cancer patients
2. St. Jude finds factors that accelerate resistance to targeted therapy in lymphoblastic leukemia
3. UC health news: molecular pathway may predict chemotherapy effectiveness
4. MIT works toward safer gene therapy
5. Intravenous gene therapy protects normal tissue of mice during whole-body radiation
6. Gene, stem cell therapy only needs to be 50 percent effective to create a healthy heart
7. Fourth Annual International Conference on Cell Therapy for Cardiovascular Diseases
8. Safe and effective therapy discovered for patients with protein-losing enteropathy
9. Ireland Cancer Center researchers advance stem cell gene therapy
10. Dolphin therapy a dangerous fad, Emory researchers warn
11. Cancer and arthritis therapy may be promising treatment for diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2018)... SAN DIEGO (PRWEB) , ... December 04, 2018 ... ... to leverage Fastec’s extensive expertise and existing IP in the development of innovative ... technology has been integrated into diverse systems from microfluidics to industrial machinery and ...
(Date:11/29/2018)... OF PRUSSIA, Pa. (PRWEB) , ... November 29, ... ... an equity investment in Semba Biosciences with the intention of acquiring full ownership. ... an Equity Participation Agreement was executed on November 14, 2018. “We are extremely ...
(Date:11/27/2018)... ... November 26, 2018 , ... ... MD, Founder of the website IBDwatch and Gastroenterology Fellow at the University of ... doctors from around the world, Dr. Wuerth will bring to uBiome knowledge and ...
Breaking Biology News(10 mins):
(Date:11/15/2018)... ... November 14, 2018 , ... Hüpnos announces the ... the public. It is estimated that 90 million Americans suffer from ... partner. The resulting daytime fatigue causes extreme difficulty with concentration, focus and memory. ...
(Date:11/13/2018)... ... November 12, 2018 , ... ... in Alpharetta and Sandy Springs, now welcomes new patients for MTM® Clear Aligners. ... comfortable alternative to traditional braces in the Sandy Springs and Alpharetta areas. Constantly ...
(Date:11/13/2018)... ... November 13, 2018 , ... Sharon ... Life Science® in Grants Pass, Oregon believes in the power of talk radio ... Water Life Science® sponsors the Power of Water® on talk radio every week ...
(Date:11/9/2018)... ... November 08, 2018 , ... ... adopted a machine-learning powered approach to increasing recovery rates by creating a comprehensive ... Intelligent Collections (AIC) product developed by NLP Logix, a Jacksonville, Florida-based AI solutions ...
Breaking Biology Technology: